IL-6 and IFNy are elevated in severe mumps cases: A study of 960 mumps patients in China

Journal of Infection in Developing Countries

Volumn 8, Issue 2, 2014, Pages 208-214

  Wang, Wen ^a   Zhu, Yueke ^a   Wu, Hao ^a   Jiao, Yanmei ^a   Halm Lutterodt, Nicholas Van ^b   Li, Wei ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Clinical features; Cytokines; Mumps; T cell subtypes

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON; IFNG PROTEIN, HUMAN; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 10; INTERLEUKIN 6;

ADOLESCENT; ADULT; ARTICLE; ASEPTIC MENINGITIS; BLOOD; CHILD; CHINA; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; LENGTH OF STAY; MALE; MIDDLE AGED; MUMPS; ORCHITIS; PRESCHOOL CHILD; RETROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-6; LENGTH OF STAY; MALE; MENINGITIS, ASEPTIC; MIDDLE AGED; MUMPS; ORCHITIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84893958271     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.3557     Document Type: Article

References (30)

1. Anderson LJ, Seward JF (2008) Mumps epidemiology and immunity: the anatomy of a modern epidemic. Pediatr Infect Dis J 27: S75-79.
2. Hviid A, Rubin S, Muhlemann K (2008) Mumps. Lancet 371: 932-944.
3. Watanabe M, Suyama K, Hashimoto K, Sato M, Ohara S, Abe Y, Kawasaki Y, Yamaguchi S, Saijo M, Hosoya M (2013) Mumps Virus-Associated Acute Encephalopathy: Case Report and Review of the Literature. J Child Neurol 28: 243-245
4. Watson-Creed G, Saunders A, Scott J, Lowe L, Pettipas J, Hatchette TF (2006) Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults. CMAJ 175: 483-488.
5. Barskey AE, Schulte C, Rosen JB, Handschur EF, Rausch-Phung E, Doll MK, Cummings KP, Alleyne EO, High P, Lawler J, Apostolou A, Blog D, Zimmerman CM, Montana B, Harpaz R, Hickman CJ, Rota PA, Rota JS, Bellini WJ, Gallagher KM (2012) Mumps outbreak in Orthodox Jewish communities in the United States. N Engl J Med 367: 1704-1713.
6. Cardenosa N, Dominguez A, Camps N, Martinez A, Torner N, Navas E, Salleras L (2006) Non-preventable mumps outbreaks in schoolchildren in Catalonia. Scand J Infect Dis 38: 671-674.
7. CDC-USA (2012) Mumps outbreak on a university campus -california, 2011. MMWR Morb Mortal Wkly Rep 61: 986-989.
8. Atrasheuskaya AV, Blatun EM, Kulak MV, Atrasheuskaya A, Karpov IA, Rubin S, Ignatyev GM (2007) Investigation of mumps vaccine failures in Minsk, Belarus, 2001-2003. Vaccine 25: 4651-4658.
9. Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, Brown D, Ramsay ME (2007) Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis 13: 12-17.
10. Peltola H, Kulkarni PS, Kapre SV, Paunio M, Jadhav SS, Dhere RM (2007) Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Clin Infect Dis 45: 459-466.
11. OMS, UNICEF, Banque, Mondiale. Available on: http://whqlibdoc.who.int/publications/2010/9789242563863fr e.pdf. Accessed in 2010.
12. Bernard H, Schwarz N, Melnic A, Bucov V, Caterinciuc N, Pebody R (2010) Mumps outbreak ongoing since October 2007 in the Republic of Moldova. Euro Surveill 13. Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId= 8079
13. Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM, Hunt K, Finley CG, Leschinsky DP, O'Keefe AL, Clayton J, Kightlinger, LK, Dietle EG, Berg J, Kenyon CL, Goldstein ST, Stokley SK, Redd SB, Rota PA, Rota J, Bi D, Roush SW, Bridges CB, Santibanez TA, Parashar U, Bellini WJ, Seward JF (2008) Recent resurgence of mumps in the United States. N Engl J Med 358: 1580-1589.
14. Whyte D, O'Dea F, McDonnell C, O'Connell NH, Callinan S, Brosnan E, Dee, A, O'Sullivan (2009) Mumps epidemiology in the mid-west of Ireland 2004-2008: increasing disease burden in the university/college setting. Euro Surveill 14. Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId= 19182
15. Ong G, Goh KT, Ma S, Chew SK (2005) Comparative efficacy of Rubini, Jeryl-Lynn and Urabe mumps vaccine in an Asian population. J Infect 51: 294-298.
16. Fei FR, Feng LZ, Xu Z, Feng ZJ (2011) Epidemiology of mumps in China, 2008-2010. Disease Surveillance 26: 691-693.
17. Ichiyama T, Maeba S, Suenaga N, Saito K, Matsubara T, Furukawa S (2005) Analysis of cytokine levels in cerebrospinal fluid in mumps meningitis: comparison with echovirus type 30 meningitis. Cytokine 30: 243-247.
18. Ulane CM, Rodriguez JJ, Parisien JP, Horvath CM (2003) STAT3 ubiquitylation and degradation by mumps virus suppress cytokine and oncogene signaling. J Virol 77: 6385-6393.
19. Fujii N, Oguma K, Kimura K, Yamashita T, Ishida S, Fujinaga K, Yashiki, T (1988) Oligo-2',5'-adenylate synthetase activity in K562 cell lines persistently infected with measles or mumps virus. J Gen Virol 69: 2085-2091.
20. Fujii N, Yokosawa N, Shirakawa S (1999) Suppression of interferon response gene expression in cells persistently infected with mumps virus, and restoration from its suppression by treatment with ribavirin. Virus Res 65: 175-185.
21. Yokosawa N, Yokota S, Kubota T, Fujii N (2002) C-terminal region of STAT-1alpha is not necessary for its ubiquitination and degradation caused by mumps virus V protein. J Virol 76: 12683-12690.
22. Kubota T, Yokosawa N, Yokota S, Fujii N (2001) C terminal CYS-RICH region of mumps virus structural V protein correlates with block of interferon alpha and gamma signal transduction pathway through decrease of STAT 1-alpha. Biochem Biophys Res Commun 283: 255-259.
23. Darnell JE Jr (1997) STATs and gene regulation. Science 277: 1630-1635.
24. Dhiman N, Ovsyannikova IG, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA (2008) Associations between cytokine/cytokine receptor single nucleotide polymorphisms and humoral immunity to measles, mumps and rubella in a Somali population. Tissue Antigens 72: 211-220.
25. Ovsyannikova IG, Jacobson RM, Dhiman N, Vierkant RA, Pankratz VS, Poland GA (2008) Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine. Pediatrics 121: e1091-1099.
26. Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G (1993) Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 178: 2207-2211.
27. Hirano T (1998) Interleukin 6 and its receptor: ten years later. Int Rev Immunol 16: 249-284.
28. Rincon M (2012) Interleukin-6: from an inflammatory marker to a target for inflammatory diseases. Trends Immunol 33: 571-577.
29. Boehm U, Klamp T, Groot M, Howard JC (1997) Cellular responses to interferon-gamma. Annu Rev Immunol 15: 749-795.
30. Xu P, Luthra P, Li Z, Fuentes S, D'Andrea JA, Wu J (2012) The V protein of mumps virus plays a critical role in pathogenesis. J Virol 86: 1768-1776.